These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18616903)

  • 21. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovulation induction in polycystic ovary syndrome.
    Vause TDR; Cheung AP;
    J Obstet Gynaecol Can; 2010 May; 32(5):495-502. PubMed ID: 20500959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulation induction management of PCOS.
    Guzick DS
    Clin Obstet Gynecol; 2007 Mar; 50(1):255-67. PubMed ID: 17304040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of infertility in polycystic ovary syndrome: a brief update.
    Costello MF; Misso ML; Wong J; Hart R; Rombauts L; Melder A; Norman RJ; Teede HJ
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):400-3. PubMed ID: 22639834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.
    Gorry A; White DM; Franks S
    Endocrine; 2006 Aug; 30(1):27-33. PubMed ID: 17185789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.
    Cristello F; Cela V; Artini PG; Genazzani AR
    Gynecol Endocrinol; 2005 Dec; 21(6):340-52. PubMed ID: 16390783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
    Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R
    Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.
    Chakraborty P; Goswami SK; Rajani S; Sharma S; Kabir SN; Chakravarty B; Jana K
    PLoS One; 2013; 8(5):e64446. PubMed ID: 23700477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H; Paudel KR; Sharma M
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women.
    Tulppala M; Stenman UH; Cacciatore B; Ylikorkala O
    Br J Obstet Gynaecol; 1993 Apr; 100(4):348-52. PubMed ID: 8494836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
    Leeman L; Acharya U
    J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polycystic ovary syndrome: what are the obstetrical risks?].
    Bruyneel A; Catteau-Jonard S; Decanter C; Clouqueur E; Tomaszewski C; Subtil D; Dewailly D; Robin G
    Gynecol Obstet Fertil; 2014 Feb; 42(2):104-111. PubMed ID: 24485279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.